Haloperidol Tablet
Product Images NDC 0832-1540

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 0832-1540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Haloperidol 01)

FDA Label Image

Principal Display Panel (0.5 mg Tablet Bottle Label)

This is a medication description. The tablets contain Haloperidol ISP 0.5mg which is distributed by Upsher-Smith Laboratories. The tablets are designed to be light-resistant and should be kept away from children. The text indicates the tablets are only available by Rx prescription, and the copyright date is 2019. There is also a statement saying "NO VARNISH," which is not clear whether it has any relevance to the medication description.*

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

This is a description of Haloperidol Tablets, USP with a concentration of 1mg of Haloperidol USP. A bottle contains 100 tablets with the usual dosage information inside the package. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) and kept away from children. The tablets are distributed by Upsher-Smith Laboratories in Maple Grove, MN. The text also includes a copyright notice and a reference number.*

FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

This is a description of a medication called Tablets, USP that contains 2mg of Hakopenddl USP in each tablet. It warns to keep out of reach of children and is distributed by Upsher-Smith Laboratories, LLC. The copyright is from 2010.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

This is a medication description for a tablet containing 5mg of Haloperidal USP, a drug used to treat disorders such as schizophrenia and other psychotic conditions. The tablets come in a bottle containing 100 tablets and are available only with a prescription. The manufacturer is Upsher-Smith Laboratories.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

This is a medication bottle for Haloperid USP tablets. Each tablet contains 10mg of Haloperid USP. The recommended dosage is not available and should be checked from the package insert. The tablets should be stored at 20°C to 25°C in a cool, dry place, away from light and moisture. The bottle should be tightly closed after use and kept out of reach of children. The manufacturer is Upsher-Smith Laboratories, LLC located in Maple Grove, MN. The bottle is labeled 20084 ROG19.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

This is a description of a medication tablet manufactured by Upsher-Smith Laboratories. It contains 20mg of Haloperidol USP, which is commonly used to treat mental/mood disorders such as schizophrenia. The tablets are available by prescription only and come in a bottle of 100 tabs. The address of the manufacturing company is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.